Shares of Gerresheimer AG (ETR:GXI – Get Free Report) were up 0.8% during mid-day trading on Tuesday . The stock traded as high as €97.65 ($106.14) and last traded at €96.45 ($104.84). Approximately 66,736 shares traded hands during trading, a decline of 53% from the average daily volume of 140,925 shares. The stock had previously closed at €95.70 ($104.02).
Gerresheimer Price Performance
The company’s 50 day moving average price is €101.28 and its 200-day moving average price is €100.10. The stock has a market cap of $3.32 billion, a P/E ratio of 27.60, a P/E/G ratio of 0.82 and a beta of 0.91. The company has a quick ratio of 0.40, a current ratio of 0.89 and a debt-to-equity ratio of 76.38.
Gerresheimer Company Profile
Gerresheimer AG, together with its subsidiaries, manufactures and sells medicine packaging, drug delivery devices, and solutions in Germany and internationally. It operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The company offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and glass bottles and jars, as well as caps, closures, applicators, and accessories; development, industrialization and contract manufacturing of drug delivery programs; project and quality management; and drug delivery systems, including inhalers, injection/auto injectors, pen injectors, infusion systems, and inhalation assessment, autoinjector, and other services.
Featured Articles
- Five stocks we like better than Gerresheimer
- What Is WallStreetBets and What Stocks Are They Targeting?
- Viking Therapeutics: Pharma Stock Soars on Positive Earnings
- Stock Splits, Do They Really Impact Investors?
- Top 3 Small Cap Stocks Emerging as Rotation Winners
- What is MarketRankā¢? How to Use it
- Bargain Alert: 3 Stocks Worth Watching While The Market Cools
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.